Published in Transplant Proc on February 01, 1993
Stromal gene signatures in large-B-cell lymphomas. N Engl J Med (2008) 11.34
Which cyclosporin formulation? Lancet (1996) 3.34
Consensus statement on the live organ donor. JAMA (2000) 3.29
Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group. Circulation (1996) 3.14
Analgesics and the kidney: summary and recommendations to the Scientific Advisory Board of the National Kidney Foundation from an Ad Hoc Committee of the National Kidney Foundation. Am J Kidney Dis (1996) 2.30
Synergistic effects of cyclosporine and rapamycin in a chronic nephrotoxicity model. Transplantation (1996) 2.24
Cryobiopsy increases the diagnostic yield of endobronchial biopsy: a multicentre trial. Eur Respir J (2011) 2.09
Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma. Leukemia (2007) 2.03
A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Mycophenolate Mofetil Investigators. Transplantation (1998) 1.97
Native but not denatured recombinant human immunodeficiency virus type 1 gp120 generates broad-spectrum neutralizing antibodies in baboons. J Virol (1992) 1.94
Stability of triple helices containing RNA and DNA strands: experimental and molecular modeling studies. Nucleic Acids Res (1993) 1.84
The influence of dosage regimen on experimental gentamicin nephrotoxicity: dissociation of peak serum levels from renal failure. J Infect Dis (1979) 1.83
Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the future. Am J Kidney Dis (2000) 1.68
Cyst decompression surgery for autosomal dominant polycystic kidney disease. J Am Soc Nephrol (1992) 1.68
Aortico-left ventricular tunnel: a clinical review and new surgical classification. Ann Thorac Surg (1988) 1.66
Array-based DNA methylation profiling in follicular lymphoma. Leukemia (2009) 1.63
Cationic microparticles: A potent delivery system for DNA vaccines. Proc Natl Acad Sci U S A (2000) 1.63
TRK-fused gene (TFG) is a new partner of ALK in anaplastic large cell lymphoma producing two structurally different TFG-ALK translocations. Blood (1999) 1.59
Morphine and phenytoin binding to plasma proteins in renal and hepatic failure. Clin Pharmacol Ther (1975) 1.59
Polyaspartic acid prevents experimental aminoglycoside nephrotoxicity. J Infect Dis (1989) 1.57
The role of modified purine 64 in initiator/elongator discrimination of tRNA(iMet) from yeast and wheat germ. Nucleic Acids Res (1990) 1.55
Recurrent genetic aberrations in thymoma and thymic carcinoma. Am J Pathol (2000) 1.53
Discrete subaortic stenosis: an acquired heart disease. Eur J Cardiothorac Surg (1998) 1.53
Distribution of DNA vaccines determines their immunogenicity after intramuscular injection in mice. J Immunol (2000) 1.48
Renal manifestations of sarcoidosis. Arch Intern Med (1981) 1.47
Prolonged intestinal exposure to amniotic fluid does not result in peel formation in gastroschisis. J Pediatr Surg (1999) 1.46
Heart transplantation in patients with previous cardiac operations. Excellent clinical results. J Thorac Cardiovasc Surg (1994) 1.46
Can recognition of living things be selectively impaired? Neuropsychologia (1991) 1.44
Transplantation with older donor hearts for presumed "stable" recipients: an analysis of the Joint International Society for Heart and Lung Transplantation/United Network for Organ Sharing Thoracic Registry. J Heart Lung Transplant (1998) 1.42
Cyclosporine and vancomycin disposition during continuous venovenous hemodiafiltration. Ann Pharmacother (1995) 1.41
First-in-human study of the safety and efficacy of TOL101 induction to prevent kidney transplant rejection. Am J Transplant (2014) 1.41
Acute renal failure from ticrynafen. N Engl J Med (1979) 1.40
Evidence for water channels in renal proximal tubule cell membranes. J Membr Biol (1987) 1.39
The selenocysteine-inserting opal suppressor serine tRNA from E. coli is highly unusual in structure and modification. Nucleic Acids Res (1989) 1.36
Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation. Transplantation (1998) 1.36
The influence of tobramycin dosage regimens on nephrotoxicity, ototoxicity, and antibacterial efficacy in a rat model of subcutaneous abscess. J Infect Dis (1988) 1.36
Action and toxicity of cyclosporine. Annu Rev Med (1986) 1.35
Lymphomas expressing ALK fusion protein(s) other than NPM-ALK. Blood (1999) 1.35
The 3'-terminal end (NCCA) of tRNA determines the structure and stability of the aminoacyl acceptor stem. Proc Natl Acad Sci U S A (1993) 1.35
Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies. Curr Opin Crit Care (2001) 1.32
Dendritic cells internalize vaccine adjuvant after intramuscular injection. Cell Immunol (1998) 1.25
Lead nephropathy. Kidney Int (1985) 1.24
The effect of adjuvants on the efficacy of a recombinant herpes simplex virus glycoprotein vaccine. J Immunol (1988) 1.23
Chronic cyclosporine nephropathy: the Achilles' heel of immunosuppressive therapy. Kidney Int (1996) 1.22
The nephropathy of the nail-patella syndrome. Clinicopathologic analysis of 11 kindred. Am J Med (1973) 1.20
Non-nodal type of mantle cell lymphoma is a specific biological and clinical subgroup of the disease. Leukemia (2012) 1.17
Genetic rearrangement of FOXP1 is predominantly detected in a subset of diffuse large B-cell lymphomas with extranodal presentation. Leukemia (2006) 1.17
EGFR-tyrosine kinase inhibitor treatment beyond progression in long-term Caucasian responders to erlotinib in advanced non-small cell lung cancer: a case-control study of overall survival. Lung Cancer (2013) 1.16
Drug prescribing in renal failure: dosing guidelines for adults. Am J Kidney Dis (1983) 1.13
Biochemical detection of novel anaplastic lymphoma kinase proteins in tissue sections of anaplastic large cell lymphoma. Am J Pathol (1999) 1.13
Lack of objective improvement in ventricular systolic function in patients with myocarditis treated with azathioprine and prednisone. J Am Coll Cardiol (1985) 1.12
Vancomycin pharmacokinetics, renal handling, and nonrenal clearances in normal human subjects. Clin Pharmacol Ther (1988) 1.12
Endogenous creatinine clearance as a clinical measure of glomerular filtration rate. Br Med J (1971) 1.12
The Registry of the International Society for Heart and Lung Transplantation: fifteenth official report--1998. J Heart Lung Transplant (1998) 1.11
Guidelines for drug therapy in renal failure. Ann Intern Med (1977) 1.10
Gentamicin and tobramycin nephrotoxicity. A morphologic and functional comparison in the rat. Am J Pathol (1978) 1.10
Drug-related syndromes in clinical nephrology. Ann Intern Med (1977) 1.10
Pathogenesis of cyclosporine nephropathy: roles of angiotensin II and osteopontin. J Am Soc Nephrol (1995) 1.09
Nephrotoxic acute renal failure due to common drugs. Am J Physiol (1981) 1.09
Interaction of a selenocysteine-incorporating tRNA with elongation factor Tu from E.coli. Nucleic Acids Res (1990) 1.08
Renal function 27 years after unilateral nephrectomy for related donor kidney transplantation. J Urol (1988) 1.08
In vitro generation of antigen-specific hemolytic plaque-forming cells from human peripheral blood mononuclear cells. J Exp Med (1981) 1.08
Attenuation of experimental tobramycin nephrotoxicity by ticarcillin. Antimicrob Agents Chemother (1985) 1.08
Proposal to add a factor of evidence to the TNM system. Int J Cancer (1971) 1.07
Cyclosporine nephrotoxicity. Ann Intern Med (1983) 1.07
Pulmonary sarcoidosis: patterns of cytokine release in vitro. Eur Respir J (1996) 1.07
Renal cholesterol accumulation: a durable response after acute and subacute renal insults. Am J Pathol (2001) 1.05
Cyst fluid antibiotic concentrations in autosomal-dominant polycystic kidney disease. Am J Kidney Dis (1985) 1.04
Reversibility of gentamicin nephrotoxicity in rats: recovery during continuous drug administration. Proc Soc Exp Biol Med (1979) 1.04
Recurrence of sarcoidosis in a cardiac allograft: control with augmented corticosteroids. J Heart Lung Transplant (1992) 1.04
Effect of sodium intake on gentamicin nephrotoxicity in the rat. Proc Soc Exp Biol Med (1976) 1.04
Genetic factors predisposing to chronic lymphocytic leukemia and to autoimmune disease. Medicine (Baltimore) (1980) 1.04
Role of splenectomy in renal transplantation. Urology (1973) 1.04
Coarctation of the aorta in patients younger than three months. A critique of the subclavian flap operation. J Thorac Cardiovasc Surg (1985) 1.04
Drug dosing guidelines in patients with renal failure. West J Med (1992) 1.03
Trimethoprim-sulfamethoxazole in cyst fluid from autosomal dominant polycystic kidneys. Kidney Int (1987) 1.03
Ciprofloxacin activity in cyst fluid from polycystic kidneys. Antimicrob Agents Chemother (1988) 1.03
Djenkol bean poisoning (djenkolism): an unusual cause of acute renal failure. Am J Kidney Dis (1995) 1.02
Drug therapy in renal failure: dosing guidelines for adults. Part II: sedatives, hypnotics, and tranquilizers; cardiovascular, antihypertensive, and diuretic agents; miscellaneous agents. Ann Intern Med (1980) 1.02
A 3-cM commonly deleted region in 6q21 in leukemias and lymphomas delineated by fluorescence in situ hybridization. Genes Chromosomes Cancer (2000) 1.02
Cationic microparticles are an effective delivery system for immune stimulatory cpG DNA. Pharm Res (2001) 1.02
Lymphadenopathy: differentiation of benign from malignant disease--color Doppler US assessment of intranodal angioarchitecture. Radiology (1998) 1.02
A guide to drug therapy in renal failure. JAMA (1974) 1.01
Vascular mechanisms of cyclosporin-induced hypertension in the rat. J Clin Invest (1994) 1.01
Cyclosporine-induced acute renal dysfunction in the rat. Evidence of arteriolar vasoconstriction with preservation of tubular function. Transplantation (1987) 1.01
Tacrolimus induces increased expression of transforming growth factor-beta1 in mammalian lymphoid as well as nonlymphoid cells. Transplantation (1999) 1.01
Long-term protection of polyaspartic acid in experimental gentamicin nephrotoxicity. Antimicrob Agents Chemother (1991) 1.00
Molecular characterization of 11q deletions points to a pathogenic role of the ATM gene in mantle cell lymphoma. Blood (1999) 1.00
Effect of donor age and ischemic time on intermediate survival and morbidity after lung transplantation. Chest (2000) 1.00
Ethylene glycol intoxication. Prevention of renal failure by aggressive management. JAMA (1973) 1.00
Macroscopic hematuria in mesangial IgA nephropathy: correlation with glomerular crescents and renal dysfunction. Kidney Int (1983) 1.00
Induction of contraction in isolated rat aorta by cyclosporine. Transplantation (1987) 1.00
[Therapy of bone tumors. Results of a collective study of 527 cases]. Chirurg (1974) 0.99
Erythropoiesis in vitro. Role of calcium. J Clin Invest (1979) 0.99
Postrenal transplant erythrocytosis: a review of 53 patients. Kidney Int (1983) 0.99
T-cell receptor variable beta genes show differential expression in CD4 and CD8 T cells. Hum Immunol (1991) 0.99